Search Results - "Bohn, M"

Refine Results
  1. 1

    Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism by Luttrell, Louis M, Maudsley, Stuart, Bohn, Laura M

    Published in Molecular pharmacology (01-09-2015)
    “…The fact that over 30% of current pharmaceuticals target heptahelical G protein-coupled receptors (GPCRs) attests to their tractability as drug targets…”
    Get more information
    Journal Article
  2. 2

    Toward Directing Opioid Receptor Signaling to Refine Opioid Therapeutics by Grim, Travis W., Acevedo-Canabal, Agnes, Bohn, Laura M.

    Published in Biological psychiatry (1969) (01-01-2020)
    “…The mu opioid receptor (MOR) is a diversely regulated target for the alleviation of pain in the clinical setting. However, untoward side effects such as…”
    Get full text
    Journal Article
  3. 3

    Crystal Structure of the Human Cannabinoid Receptor CB1 by Hua, Tian, Vemuri, Kiran, Pu, Mengchen, Qu, Lu, Han, Gye Won, Wu, Yiran, Zhao, Suwen, Shui, Wenqing, Li, Shanshan, Korde, Anisha, Laprairie, Robert B., Stahl, Edward L., Ho, Jo-Hao, Zvonok, Nikolai, Zhou, Han, Kufareva, Irina, Wu, Beili, Zhao, Qiang, Hanson, Michael A., Bohn, Laura M., Makriyannis, Alexandros, Stevens, Raymond C., Liu, Zhi-Jie

    Published in Cell (20-10-2016)
    “…Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chemical from Cannabis sativa with a wide range of…”
    Get full text
    Journal Article
  4. 4

    Bias Factor and Therapeutic Window Correlate to Predict Safer Opioid Analgesics by Schmid, Cullen L., Kennedy, Nicole M., Ross, Nicolette C., Lovell, Kimberly M., Yue, Zhizhou, Morgenweck, Jenny, Cameron, Michael D., Bannister, Thomas D., Bohn, Laura M.

    Published in Cell (16-11-2017)
    “…Biased agonism has been proposed as a means to separate desirable and adverse drug responses downstream of G protein-coupled receptor (GPCR) targets. Herein,…”
    Get full text
    Journal Article
  5. 5

    Crystal Structure of the Human Cannabinoid Receptor CB2 by Li, Xiaoting, Hua, Tian, Vemuri, Kiran, Ho, Jo-Hao, Wu, Yiran, Wu, Lijie, Popov, Petr, Benchama, Othman, Zvonok, Nikolai, Locke, K’ara, Qu, Lu, Han, Gye Won, Iyer, Malliga R., Cinar, Resat, Coffey, Nathan J., Wang, Jingjing, Wu, Meng, Katritch, Vsevolod, Zhao, Suwen, Kunos, George, Bohn, Laura M., Makriyannis, Alexandros, Stevens, Raymond C., Liu, Zhi-Jie

    Published in Cell (24-01-2019)
    “…The cannabinoid receptor CB2 is predominately expressed in the immune system, and selective modulation of CB2 without the psychoactivity of CB1 has therapeutic…”
    Get full text
    Journal Article
  6. 6

    Crystal structures of agonist-bound human cannabinoid receptor CB1 by Hua, Tian, Vemuri, Kiran, Nikas, Spyros P., Laprairie, Robert B., Wu, Yiran, Qu, Lu, Pu, Mengchen, Korde, Anisha, Jiang, Shan, Ho, Jo-Hao, Han, Gye Won, Ding, Kang, Li, Xuanxuan, Liu, Haiguang, Hanson, Michael A., Zhao, Suwen, Bohn, Laura M., Makriyannis, Alexandros, Stevens, Raymond C., Liu, Zhi-Jie

    Published in Nature (London) (27-07-2017)
    “…Crystal structures of the human cannabinoid receptor 1 (CB 1 ) bound to the agonists AM11542 and AM841 reveal notable structural rearrangements upon receptor…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics by Raehal, Kirsten M., Bohn, Laura M.

    Published in Neuropharmacology (01-01-2011)
    “…Ligands acting at the same receptor can differentially activate distinct signal transduction pathways, which in turn, can have diverse functional consequences…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Zinc-Assisted Hydrodeoxygenation of Biomass-Derived 5-Hydroxymethylfurfural to 2,5-Dimethylfuran by Saha, Basudeb, Bohn, Christine M., Abu-Omar, Mahdi M.

    Published in ChemSusChem (01-11-2014)
    “…2,5‐Dimethylfuran (DMF), a promising cellulosic biofuel candidate from biomass derived intermediates, has received significant attention because of its low…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria by Brust, Tarsis F, Morgenweck, Jenny, Kim, Susy A, Rose, Jamie H, Locke, Jason L, Schmid, Cullen L, Zhou, Lei, Stahl, Edward L, Cameron, Michael D, Scarry, Sarah M, Aubé, Jeffrey, Jones, Sara R, Martin, Thomas J, Bohn, Laura M

    Published in Science signaling (29-11-2016)
    “…Agonists targeting the kappa opioid receptor (KOR) have been promising therapeutic candidates because of their efficacy for treating intractable itch and…”
    Get more information
    Journal Article
  13. 13

    An evaluation of Mg/Ca, Sr/Ca, and Ba/Ca ratios as environmental proxies in aragonite bivalve shells by Poulain, C., Gillikin, D.P., Thébault, J., Munaron, J.M., Bohn, M., Robert, R., Paulet, Y.-M., Lorrain, A.

    Published in Chemical geology (09-03-2015)
    “…The influence of salinity and water chemistry on Mg/Ca, Sr/Ca, and Ba/Ca ratios in the aragonitic shells of the Manila clam was investigated. Clams were reared…”
    Get full text
    Journal Article
  14. 14

    U–Th stratigraphy of a cold seep carbonate crust by Bayon, G., Henderson, G.M., Bohn, M.

    Published in Chemical geology (15-03-2009)
    “…On continental margins, oxidation of methane-rich fluids from the sediment often leads to formation of authigenic carbonate pavements on the seafloor. The…”
    Get full text
    Journal Article
  15. 15

    Desensitization of G protein-coupled receptors and neuronal functions by GAINETDINOV, Raul R, PREMONT, Richard T, BOHN, Laura M, LEFKOWITZ, Robert J, CARON, Marc G

    Published in Annual review of neuroscience (01-01-2004)
    “…G protein-coupled receptors (GPCRs) have proven to be the most highly favorable class of drug targets in modern pharmacology. Over 90% of nonsensory GPCRs are…”
    Get full text
    Journal Article
  16. 16

    Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo by Schmid, Cullen L, Raehal, Kirsten M, Bohn, Laura M

    “…Visual and auditory hallucinations accompany certain neuropsychiatric disorders, such as schizophrenia, and they also can be induced by the use or abuse of…”
    Get full text
    Journal Article
  17. 17

    Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain by Pantouli, Fani, Grim, Travis W., Schmid, Cullen L., Acevedo-Canabal, Agnes, Kennedy, Nicole M., Cameron, Michael D., Bannister, Thomas D., Bohn, Laura M.

    Published in Neuropharmacology (01-03-2021)
    “…The mu opioid receptor-selective agonist, SR-17018, preferentially activates GTPγS binding over βarrestin2 recruitment in cellular assays, thereby…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence by Tonnelet, David, Bohn, M. D. Pierre, Becker, Stephanie, Decazes, Pierre, Camus, Vincent, Thureau, Sebastien, Tilly, Hervé, Jardin, Fabrice, Vera, Pierre

    Published in EJNMMI research (12-04-2021)
    “…Background Our aim was to measure the impact of two cycles of standard chemotherapy on tumoural neoangiogenesis by [ 18 F] fluorine arginine-glycine-aspartic…”
    Get full text
    Journal Article
  20. 20

    Structure of an affinity-matured inhibitory recombinant fab against urokinase plasminogen activator reveals basis of potency and specificity by Sevillano, N., Bohn, M.F., Zimanyi, M., Chen, Y., Petzold, C., Gupta, S., Ralston, C.Y., Craik, C.S.

    “…Affinity maturation of U33, a recombinant Fab inhibitor of uPA, was used to improve the affinity and the inhibitory effect compared to the parental Fab…”
    Get full text
    Journal Article